市場調查報告書
商品編碼
1422804
2024-2032 年按類型(全自動、半自動)、應用(醫院、診斷實驗室、放射診所等)和地區分類的自動放射合成模組市場報告Automated Radiosynthesis Module Market Report by Type (Fully Automated, Semi-Automated), Application (Hospitals, Diagnostic Labs, Radiology Clinics, and Others), and Region 2024-2032 |
2023年,全球自動放射合成模組市場規模達到3,410萬美元。展望未來, IMARC Group預計到2032年市場規模將達到5,710萬美元,2024-2032年複合年成長率(CAGR)為5.72%。各種慢性病和心血管疾病的盛行率不斷上升,尤其是在老年族群中,加上醫療保健領域對PET 和SPECT 掃描儀創建斷層掃描影像的需求不斷成長,以及醫療保健領域的進步,是推動市場發展的一些關鍵因素。
自動放射合成模組是指先進的醫療設備,旨在以示蹤劑分子配製放射性同位素,適合執行密集的診斷和治療程序。自動放射合成模組也採用正子斷層掃描(PET)和單光子發射電腦斷層掃描(SPECT)掃描儀。這些解決方案提高了斷層成像診斷方法的實用性。與放射性示踪劑和放射性藥物裝置相比,它在執行診斷和治療管理時提供了更好的生產客製化範圍、更長的設備壽命、設置便利性以及更好的操作效率。除此之外,自動放射合成模組易於使用並改善治療監測活動。因此,它被醫療保健從業者廣泛應用於醫院、實驗室和診所。目前,自動放射合成模組已商業化,有全自動和半自動兩種類型。
包括癌症和慢性阻塞性肺病(COPD)在內的各種慢性和心血管疾病的盛行率不斷增加,是推動市場成長的主要因素。此外,醫療保健領域對 PET 和 SPECT 掃描儀創建斷層影像的需求不斷成長,促進了醫療保健領域對自動放射合成模組的需求,這是另一個成長誘導因素。與此一致的是,一些政府在分散環境中對放射性示蹤劑生產的大規模投資進一步促進了市場成長。此外,人們對多種產品優勢(例如低資本成本、最低基礎設施要求和最佳性能)的認知不斷提高,正在支持市場成長。這可以進一步歸因於其用途、功能和功效方面的重大技術進步,這極大地有利於市場成長。此外,易患慢性病的老年人口不斷增加,以及全球死亡率不斷上升,正在推動市場成長。其他因素,例如醫療保健基礎設施的顯著增強、最近的研發(R&D) 活動以及主要參與者之間為設計具有更高功效的新產品替代品而進行的重大戰略合作,正在為市場成長創造積極的前景。該市場還受到醫療保健行業的顯著擴張以及政府和私人組織提供的資金和贈款的推動,以鼓勵在各種應用中採用自動放射合成模組。
The global automated radiosynthesis module market size reached US$ 34.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 57.1 Million by 2032, exhibiting a growth rate (CAGR) of 5.72% during 2024-2032. The increasing prevalence of various chronic and cardiovascular diseases, especially amongst the geriatric population, along with the rising need for PET and SPECT scanners in the healthcare sector to create tomographic images and advancements in the healthcare sector represent some of the key factors driving the market.
Automated radiosynthesis module refers to advanced medical equipment designed to formulate the radioactive isotope with a tracer molecule that is suitable to perform intensive diagnostic and therapeutic procedures. The automated radiosynthesis module also employs positron emission tomography (PET) and single-photon emission computerized tomography (SPECT) scanners. These solutions improve the utility of tomographic imaging diagnostics methods. As compared to radiotracers and radiopharmaceutical units, it offers better scope for production customization, longer device life, setting-up convenience, and better operational efficiency while performing diagnosis and therapy administration. Along with this, the automated radiosynthesis module is readily usable and improves therapy monitoring activities. Consequently, it is extensively used across hospitals, laboratories, and clinics by healthcare practitioners. At present, automated radiosynthesis module is commercially available in full and semi-automated types.
The increasing prevalence of various chronic and cardiovascular diseases, including cancer and chronic obstructive pulmonary disorders (COPD), represents a prime factor driving the market growth. Additionally, the rising need for PET and SPECT scanners in the healthcare sector to create tomographic images have facilitated the demand for automated radiosynthesis module in the healthcare sector, which is acting as another growth-inducing factor. In line with this, the large-scale investments being made by several governments in the production of radiotracers in decentralized settings are further contributing to the market growth. Moreover, the rising awareness regarding the multiple product benefits, such as low capital cost, minimal infrastructural requirement, and optimal performance, is supporting the market growth. This can be further attributed to significant technological advancements in terms of its usage, features, and efficacy, which is considerably favoring the market growth. Additionally, the rising geriatric population, which is susceptible to chronic ailments, and the escalating mortality rates across the globe are propelling the market growth. Other factors, such as significant enhancements in the healthcare infrastructure, the recent research and development (R&D) activities, and the major strategic collaborations amongst key players to engineer new product alternatives with enhanced efficacy, are creating a positive outlook for the market growth. The market is also being driven by the significant expansion in the healthcare industry, along with funding and grants provided by government and private organizations to encourage the adoption of automated radiosynthesis module for various applications.
IMARC Group provides an analysis of the key trends in each segment of the global automated radiosynthesis module market, along with forecasts at the global, regional, and country level from 2024-2032. Our report has categorized the market based on type and application.
Fully Automated
Semi-Automated
The report has also provided a detailed breakup and analysis of the automated radiosynthesis module market based on the type. This includes fully and semi-automated. According to the report, fully automated represented the largest segment.
Hospitals
Diagnostic Labs
Radiology Clinics
Others
A detailed breakup and analysis of the automated radiosynthesis module market based on the application has also been provided in the report. This includes hospitals, diagnostic labs, radiology clinics, and others. According to the report, hospitals accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets that include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for automated radiosynthesis module. Some of the factors driving the North America automated radiosynthesis module market included the increasing prevalence of various chronic and cardiovascular diseases, significant technological advancements, and extensive research and development (R&D) activities.
The report has also provided a comprehensive analysis of the competitive landscape in the global automated radiosynthesis module market. Detailed profiles of all major companies have also been provided. Some of the companies covered includes Eckert & Ziegler Strahlen- und Medizintechnik AG, Elysia S.A., General Electric Company, IBA RadioPharma Solutions, Optimized Radiochemical Applications, SCINTOMICS Molecular, Applied Theranostics Technologies GmbH, Synthra GmbH, Trasis, etc.